Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility

A Espinel-Ingroff1, A Fothergill, M Ghannoum

  • 1VCU Medical Center, 1101 E. Marshall Street, Sanger Hall, Room 7-049, P.O. Box 980049, Richmond, VA 23298-0049, USA. avingrof@vcu.edu

Insights

This study assessed anidulafungin antifungal susceptibility testing for filamentous fungi. Optimal conditions were identified, showing high reproducibility for molds like Aspergillus, Fusarium, and Scedosporium.

Area of Science:

  • Medical Mycology
  • Antimicrobial Susceptibility Testing
  • Clinical Microbiology

Background:

  • Current Clinical and Laboratory Standards Institute (CLSI) M38-A guidelines lack echinodin recommendations.
  • Antifungal susceptibility testing (AFST) is crucial for treating mold infections.

Purpose of the Study:

  • To evaluate the inter- and intralaboratory reproducibility of anidulafungin AFST against filamentous fungi.
  • To determine optimal reading times and endpoints for anidulafungin susceptibility testing.

Main Methods:

  • A multicenter study involving eight laboratories.
  • Testing anidulafungin against Aspergillus, Fusarium, Paecilomyces, and Scedosporium isolates.
  • Assessing minimum inhibitory concentrations (MICs) and minimum effective concentrations (MECs) at various time points (24, 48, 72 hours).

Main Results:

  • 100% reproducibility for anidulafungin MECs at 24 hours for Aspergillus and Paecilomyces.
  • High reproducibility (94-97.5%) for Fusarium and Scedosporium isolates at 48 or 72 hours.
  • Established optimal testing conditions for anidulafungin against key mold species.

Conclusions:

  • The study identified reliable testing conditions for anidulafungin against molds.
  • Recommendations for incorporating these findings into future CLSI M38 guidelines are warranted.
  • Standardized testing will improve clinical management of fungal infections.

Related Concept Videos